A woman recovering from breast cancer sits tethered to a wall-mounted machine for hours each day, unable to move freely while fluid drains from her arm. Across the globe, hundreds of thousands of cancer survivors face the same frustrating reality. They manage lymphedema—painful swelling caused when lymph nodes are removed or damaged during treatment—using equipment so bulky it confines them to their homes. But a team of engineers at Canada’s University of Waterloo has spent years studying this problem, and they’ve arrived at an elegant solution: a portable compression sleeve no larger than a smartphone.
What began in a laboratory as an observation about constraints has evolved into a technology that could fundamentally reshape how cancer survivors live their lives after treatment ends.
When Stillness Becomes the Price of Healing
For decades, compression therapy for lymphedema has relied on the same basic design: a large control box managing multiple valves, tethered to mains power. The system is slow and dependent on wall power, forcing patients to remain seated during treatment. Current devices can cost as high as $3,000, placing them beyond reach for many. More importantly, they steal something precious from people already dealing with the aftermath of cancer: mobility, independence, and the ability to move through their days uninterrupted.
Research has documented heightened psychological distress, depression, and anxiety associated with lymphedema, often linked to feelings of hopelessness and isolation due to immobility. For cancer survivors attempting to reclaim their lives, the equipment meant to help them heal becomes another constraint.
Engineering a Different Path
Carolyn Ren, a professor in the Department of Mechanical and Mechatronics Engineering, leads the Waterloo Microfluidics Laboratory. When she examined existing compression devices, she recognised a design limitation shared across the industry. The bulky control boxes were, in a sense, a relic—engineered from necessity rather than optimisation. She began asking a different question: what if the entire system could become small enough to fit in your pocket?
The answer lay in microfluidics, a field that studies how fluids move through microscopic channels. By integrating a pump, valves, and a specially designed microfluidic chip into a single compact unit, the team created what most people would simply call a device about the size and weight of a smartphone. But the engineering elegance lies in what happens next.
The prototype connects to lightweight inflatable chambers embedded in a sleeve that gently expand and contract to apply controlled, targeted compression. A rechargeable battery powers the system for up to eight hours—long enough for overnight healing while patients sleep, or for most of a waking day if desired. For the first time, compression therapy doesn’t mean being plugged into a wall.
From Lab to Patient Living Rooms
The device remained more concept than reality until the team partnered with kinesiologist Dr. Clark Dickerson and Jacqueline Kormylo, a Waterloo graduate student whom Ren supported in becoming a certified lymphedema therapist. Kormylo understood something crucial that engineers sometimes miss: how patients actually live. She began demonstrating the sleeve with real people in Ottawa, watching how they moved, listening to their concerns, gathering the practical feedback that transforms prototypes into usable tools.
That collaboration proved transformative. Early testing revealed where designs felt uncomfortable, which positions worked best, how patients wanted to interact with the technology. Each conversation refined the sleeve’s shape, the sleeve’s pressure patterns, the battery interface.
Ren and her former graduate student Dr. Run Ze Gao now hold several patents supporting the sleeve’s path towards FDA approval and medical adoption. The path forward is neither quick nor simple, but it moves with genuine momentum.
Redesigning What Recovery Can Cost
The economics of this innovation are as significant as the engineering. The team aims to deliver full therapeutic treatment at roughly half the cost of current devices—potentially bringing therapy within reach for patients and healthcare systems that couldn’t previously afford it. This isn’t just about a lower price tag. It’s about access, about dignity, about cancer survivors not having to choose between treatment and the ability to participate in their own lives.
The team recognised early that commercialisation requires more than a good idea. The Waterloo Commercialisation Office continues to play a crucial role in this work, helping translate laboratory innovation into something the market can manufacture, distribute, and support.
Looking Beyond the Sleeve
The portable compression sleeve is not the end of this team’s ambition. Whilst refining the compression sleeve, the team is also developing a next-generation therapeutic device, a robotic hand, capable of supporting other cancer patients with lymphedema in hard-to-treat areas. The wrist, the hand, the chest—these remain stubborn challenges for compression therapy. The robotic hand represents a commitment to solving the full spectrum of lymphedema, not just the obvious cases.
When Ren reflects on why she pursues this work, she returns to a simple principle. She notes that “when innovation is driven by solving a true problem, commercialisation becomes a natural path. It never starts with ‘I want to commercialise’. It always starts with the problem.” Across the past fifteen years, she has developed multiple devices and co-founded companies with her graduate students, each time following the same compass: identify what patients actually need, then engineer a solution worthy of their struggle.
Freedom Fits in Your Pocket
As cancer treatments become more advanced and personalised, survival rates for breast and brain cancers continue to rise. This success brings a hidden cost: a growing population of survivors managing lymphedema. For decades, they’ve accepted that healing meant sitting still, tethered to machines in their homes, isolated from the forward momentum of their own recovery.
The portable compression sleeve changes that equation. A woman could wear this device beneath her clothes whilst moving through her day. A parent could supervise children at the park. Someone could return to work, to exercise, to the small freedoms that define living.
In an engineering lab in Canada, a team of scientists is quietly rewriting what recovery looks like after cancer. And they’ve done it by refusing to accept that medical necessity requires sacrificing freedom.
